In a good-news-in-the-bad-news for Southern California: The bad news: U.S., venture backed liquidity dropped significantly in Q1, to a mere $3.2 billion. The good news: 30% (yes, a third) of the liquidity for venture capital firms in the U.S. came from the sale of two Southern California companies — CoreValve and Ablation Frontiers. CoreValve was [...]
For anyone who might care, I’ve been called as a last minute, pinch hitter to moderate the SoCalBio panel Working Through the Downturn: Tips for the Bioscience Industry as Obama’s Stimulus Package Takes Effect tomorrow night (Thursday). The panel is up in Oxnard/Ventura. It should be interesting to hear how the bioscience industry is coping [...]
Quick notes The Biotech Forum, an effort to connect entrepreneurs and venture capitalists interested in the biotech industry in Los Angeles and Ventura County, and more specifically in the 101 Corridor, is next Thursday, March 27th — the effort is looking to draw from the wealth of industry experience from folks at Amgen and elsewhere [...]
I’ve covered the 101 Corridor — the stretch of the 101 Freeway running roughly from the north end of Los Angeles County up to Santa Barbara — ever since I started socalTECH many years ago, and I’ve always been surprised that this area–which is heavily dominated by Amgen–has a very paltry number of biotechnology startups. [...]
Thoughts and commentary from Benjamin F. Kuo, publisher of socalTECH.com.
